Tarsus Pharmaceuticals, Inc. TARS Unrealized gains
Unrealized gains at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:CashAndCashEquivalentsAccumulatedUnrealizedGainsBeforeTax.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s unrealized gains.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s unrealized gains?
- Tarsus Pharmaceuticals, Inc. (TARS) reported unrealized gains of $1K in Q4 2025.
- What does unrealized gains mean?
- The cumulative unrealized gains associated with cash equivalents or short-term liquid investments held by the company. This reflects the mark-to-market performance of the company's liquid treasury assets prior to any actual sale or realization.